SST and multiminicore myopathy: Therefore, the potential promise for clinical applications need to be verified by large scale and multicenter, prospective follow-up studies involving clinical samples of other unrelated vascular pathologies that can both validate the findings of our study and demonstrate the potential clinical utility of serum VIP, CCK, and SST in MMD risk prediction.